Justices Told Thyroid Drug Patent Ax Flouts Global Pact
The U.S. Supreme Court was urged to overturn a Federal Circuit ruling that a patent on the thyroid drug Tirosint is invalid as indefinite, with the patent owner arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article